Carregant...
A High-Throughput Assay for Developing Inhibitors of PhoP, a Virulence Factor of Mycobacterium tuberculosis
Tuberculosis (TB) kills over 1.5 million people per year despite the available anti-TB drugs. The emergence of drug-resistant TB poses a major threat to public health and prompts for an urgent need for new and more effective drugs. The long duration needed to treat TB by the current TB drugs, which...
Guardat en:
| Publicat a: | Comb Chem High Throughput Screen |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5542402/ https://ncbi.nlm.nih.gov/pubmed/27748178 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1386207319666161010163249 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|